Table 2.

Comparison of clinical characteristics between patients with NHL and patients with HD

NHLHD
No. of patients187
Age (y)6555 P = .04
% male3371 P = .20
Duration RA (y)1715NS
Dose MTX (g)2.42.2NS
Duration MTX (mo)6549NS
EBV3/185/7
Median overall survival (mo)Not reached27NS
Remission after MTX WD alone3/50/3
Long-term remission after MTX WD alone1/50/3
  • NS indicates not significant; WD, withdrawal.